| P2093 | author name string | Philip O Katz | |
| | Robert S Dudnick | |
| P2860 | cites work | Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors | Q34747821 |
| | Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease | Q39515150 |
| | A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease | Q42662159 |
| | Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors | Q43734554 |
| | Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough | Q43903194 |
| | Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure | Q44371344 |
| | Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus | Q44779979 |
| | Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole. | Q44851359 |
| | Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough | Q44895190 |
| | Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease | Q46539046 |
| | Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. | Q51566530 |
| | Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. | Q51580485 |
| | Proton pump inhibitors: better acid suppression when taken before a meal than without a meal | Q73023455 |
| | Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors | Q73204690 |
| | Helicobacter pylori eradication increases nocturnal acid breakthrough | Q73968026 |
| | Helicobacter pylori infection influences nocturnal gastric acid breakthrough | Q74128885 |
| | Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH | Q77417831 |
| | Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors | Q77769252 |
| | Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily | Q77769256 |
| | Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms | Q79576847 |
| P433 | issue | 1 | |
| P304 | page(s) | 29-34 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Current treatment options in gastroenterology | Q27714745 |
| P1476 | title | Nocturnal acid breakthrough on proton pump inhibitor therapy: to treat or not to treat | |
| P478 | volume | 11 | |